Gsk Share Discussion Threads

[tradermichael] 02/8/2024 13:04

Ignore broker ratings for this stock.

[davius] 02/8/2024 09:22

Pick 'n' mix in the broker ratings today...

Stifel raises GSK price target to 1,770 (1,740) pence - 'hold'
DZ Bank cuts fair value for GSK to 1,650 (1,750) pence - 'hold'
JPMorgan cuts GSK price target to 1,550 (1,660) pence - 'underweight'

[dope007] 02/8/2024 07:34

That is very good news both for GSK and future patients

[tuftymatt] 02/8/2024 07:07

A very nice bit of news here this morning.

Buying just under / just above 1500 seems money well spent here in my opinion.

Good luck all 👍🏻

[dplewis1] 02/8/2024 06:12

hTTps://www.londonstockexchange.com/news-article/GSK/fda-expands-jemperli-approval/16599392

[dplewis1] 01/8/2024 07:17

Deutsche bank cuts target price to 1850p from 1950p

[alibizzle] 01/8/2024 06:36

Pleased I sold at £15.50.abd got my money back (10k investment) . Will wait till it falls to high £14 and buy back in as I still think it can get above £17

[dope007] 31/7/2024 20:40

In the real world GSK have more than replaced those lost sales and shall replace them further going forward.These analysts consistently leave you saying WTF

[s2lowner1] 31/7/2024 20:07

Citi analyst Peter Verdult said while second quarter revenue and adjusted EPS beat expectations by 5% and 12% respectively, and full year guidance was raised, "we anticipate investor focus to fall on the lowered expectations for the vaccines division as a result of uncertainty around the target Arexvy patient population in the US following the June [Advisory Committee on Immunization Practices] meeting and slowing US Shingrix momentum."

"The vaccines portfolio was weaker, missing consensus by 9%," he noted while Shingrix missed by 20%, driven by weakness in the US.

[igoe104] 31/7/2024 15:18

Overall excellent growth. The market at times acts like a petulant child as times. And only looks at the slight negatives rather than the 95% positives...

[pierre oreilly] 31/7/2024 14:17

Another 1.4k for me at 15.09ish.

Seems an overdone fall to me on good results as far as i can tell. Anyhow, anther 900 quid income addition. I get fa interest in cash in my isa, and somehow i have a lot of cash.

A reasonable income stream addition, with the real probability of increasing share price over whatever timescale it takes. It's only this cheap due to us litigation, so a bit of a gamble on that. But it'll eventually sort itself out.

[abdullla] 31/7/2024 14:11

TM,I am doing the same but in round about way,nudge nudge, wink wink !

[tradermichael] 31/7/2024 12:23

I'm building a significant stake in the company ...... ;0)

[abdullla] 31/7/2024 12:09

GSK will never be taken over British government will see to that and put a block on it

[theoriginalwonderstuff] 31/7/2024 11:50

Thanks dp...I bought back in today but do think GSK has suffered from a lack of ambition; in the 10 or so years which have seen the AZ share price increase by a factor of five, GSK has largely remained stuck in the £12 - £16 range. It's a crying shame and I can see some opportune bid from PE taking it out and making a lot more of the company...

[mj19] 31/7/2024 11:47

SP been in this range for years

[dope007] 31/7/2024 10:40

SO one missed and others didn't. the overall picture is what matters and that picture was raised guidance despite the shingles vaccine

[alphorn] 31/7/2024 10:11

Medicines are either a 'pill for life' or a one off event. It is the former that brings in the regular revenues.

[laurence llewelyn binliner] 31/7/2024 10:10

Growth is all about cheap energy supply, make it expensive and manufacturing goes to other countries where it is not..

Refer to the former powerhouse economy of Germany, see how that is going for them with no Nordstream gas or nuclear, politicians hell bent drive to net zero will bankrupt the country before realising their policies are ruinous for business..

[geckotheglorious] 31/7/2024 10:07

MJ19
Post 33184
GSK can’t catch a break! Raises guidance and still falls

Suspect Shore Capital might have nailed the reason for the fall this morning.

Shore Capital Markets noted sales of GSK's Shingrix "missed materially", falling short of consensus by 20%. Shingrix is a shingles vaccine.

[dope007] 31/7/2024 09:42

NO thanks, and lose another UK company to foreigners? The UK is now 12th for world manufacturing and falling fast because all we do is sell off on the cheap. And now we have climate change nuts in charge expect manufacturing to crater further

[mj19] 31/7/2024 09:40

Someone should bid for this company while it's cheap

[tuftymatt] 31/7/2024 08:50

Yeah some good figures really and I see the price reaction as a bit of a weak clear out.

Circa 1500 is a long term winning entry point so I have added further this morning. In a week or so I can see this recovering to 1575 without too much trouble then challenging 1600.

Good luck all 👍🏻